RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.28−0.04 (-13.08%)
Close on Nov 20, 2026Market cap $1.43MP/E –Yield –
RedHill Biopharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2024 it was $4.85M, up 58.0% from the year before. The highest annual figure on record is $36.35M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.85M | +58.0% |
| FY2023 | Dec 31, 2023 | $3.07M | -89.2% |
| FY2022 | Dec 31, 2022 | $28.46M | -21.7% |
| FY2021 | Dec 31, 2021 | $36.35M | +32.3% |
| FY2020 | Dec 31, 2020 | $27.47M | +581.2% |
| FY2019 | Dec 31, 2019 | $4.03M | -27.0% |
| FY2018 | Dec 31, 2018 | $5.52M | +193.6% |
| FY2017 | Dec 31, 2017 | $1.88M | +1762.4% |
| FY2016 | Dec 31, 2016 | $101.00K | +3266.7% |
| FY2015 | Dec 31, 2015 | $3.00K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | $9.35M | +475.4% |
| Q2 FY2021 | Jun 30, 2021 | $10.91M | +5071.6% |
| Q2 FY2020 | Jun 30, 2020 | $6.71M | – |
| Q2 FY2019 | Jun 30, 2019 | $1.14M | – |
| Q2 FY2018 | Jun 30, 2018 | $1.63M | – |
| Q2 FY2017 | Jun 30, 2017 | $211.00K | – |
See a number that looks wrong?